Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Oncology|September 10, 2009
The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patientsByeong Seok Sohn, Tae Won Kim, Jae-Lyun Lee, et al.Journal of Medicinal Food|January 31, 2014
8-hydrocalamenene, derived from Reynoutria elliptica, suppresses constitutive STAT3 activation, inhibiting proliferation and enhancing chemosensitization of human multiple myeloma cellsDongwoo Nam, Junho Song, Sung-Moo Kim, et al.Oncology Reports|November 3, 2010
Effects of the HDAC inhibitor CG2 in combination with irinotecan, 5-fluorouracil, or oxaliplatin on HCT116 colon cancer cells and xenograftsYoung-Soon Na, Seung-Mi Kim, Kyung-Ah Jung, et al.Plos One|June 23, 2012
YM155 induces EGFR suppression in pancreatic cancer cellsYoung-Soon Na, Soo-Jin Yang, Seung-Mi Kim, et al.Oncology|February 14, 2012
Genetic polymorphisms of FcγRIIa and FcγRIIIa are not predictive of clinical outcomes after cetuximab plus irinotecan chemotherapy in patients with metastatic colorectal cancerSeong Joon Park, Yong Sang Hong, Jae-Lyun Lee, et al.The Journal of Biological Chemistry|May 26, 2012
Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF)Seung-Woo Hong, Dong-Hoon Jin, Jae-Sik Shin, et al.Pageof 3